Rheumatology is a field where many research questions remain open. ACR Convergence 2026 will bring together professionals from across the field to discuss ongoing research, scientific developments, and future directions. The meeting will take place in Orlando, Florida, from November 6–11, 2026, with Biopharma Informatic also in attendance.
The annual meeting attracts rheumatologists, researchers, healthcare professionals, and industry representatives from around the world. Biopharma Informatic's team will be among the attendees, taking part in discussions and meeting professionals working across different areas of rheumatology research.
Events like ACR Convergence go beyond the presentation of research findings. They also give professionals the opportunity to question existing approaches, compare experiences, and discuss what still needs to be investigated.
That is particularly relevant in rheumatology, where conditions can have overlapping symptoms, affect multiple organ systems, and present differently from one patient to another. Discussions around disease mechanisms, treatment approaches, and clinical study findings all contribute to a wider understanding of these conditions.
ACR Convergence creates room for these exchanges, bringing together people whose work may differ but whose interests often intersect. For those involved in clinical research, these conversations can offer useful perspectives on where further investigation is needed.
Clinical research depends on more than a promising scientific idea. It takes experienced investigators, capable research sites, well-planned studies, and coordination among the people responsible for carrying them out.
Biopharma Informatic works across these areas, collaborating with pharmaceutical sponsors, contract research organizations (CROs), investigators, and research sites.
At ACR Convergence, our team will engage with professionals bringing different experiences and perspectives from across the rheumatology field. For Biopharma Informatic, such interactions are valuable not only for building professional relationships but also for understanding the research priorities and practical considerations shaping future studies.
There is no single research question that defines rheumatology. Studies span a wide range of autoimmune and inflammatory conditions, each presenting its own challenges for researchers and clinicians.
Biopharma Informatic has various active clinical trials related to rheumatology. Our involvement in these clinical trials contributes to broader efforts to investigate these conditions and evaluate potential treatment approaches. Clinical trials give researchers a structured way to examine investigational treatments, study their safety, and learn more about their effects in people living with these diseases.
As research continues across the field, opportunities to exchange findings and discuss unanswered questions remain important. ACR Convergence provides a setting for these discussions among professionals working at different stages of clinical research and care.
Speaking about the upcoming meeting, our CEO, Shuja Naqvi, emphasized the importance of staying connected with the scientific community.
"Every research discussion offers an opportunity to look at a question from a different perspective. In rheumatology, where there is still much to learn about these conditions and their treatment, staying connected with the scientific community matters. I look forward to hearing from fellow professionals, sharing experiences, and discussing where collaboration can take future research."
Allison Brown and Ana Velazquez will be attending ACR Convergence 2026 on behalf of Biopharma Informatic. They look forward to meeting fellow attendees, including pharmaceutical sponsors, CRO representatives, investigators, and rheumatology professionals.
If you are attending, take the opportunity to meet the Biopharma Informatic team, exchange ideas, and discuss the work taking place across clinical research. Our team looks forward to making new connections and continuing conversations that support future research collaborations.
Biopharma Informatic
Email: [email protected]
Phone: 281-944-3610
Website: biopharmainfo.net